跳至主要内容
临床试验/NCT03089762
NCT03089762已完成1 期

Intra-articular Injection in the Knee of Adipose Derived Stromal Cells and Platelet Rich Plasma for Osteoarthritis

Bioheart, Inc.0 个研究点目标入组 10 人开始时间: 2012年2月12日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10
主要终点
WOMAC (Western Ontario and McMaster Universities Arthritis Index)

研究概览

简要总结

Stromal vascular fraction (SVF) can easily be obtained from a mini-lipoaspirate procedure of fat tissue and platelet rich plasma (PRP) can be obtained from peripheral blood. Evaluated the safety and preliminary efficacy of administering SVF and PRP intra-articularly into patients with osteoarthritis grade 1 and 2.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients age 50 or older who present with symptomatic primary osteoarthritis of the knee
  • daily pain for the previous 3 months
  • analgesics usage at least once a week
  • less than 30 minutes of morning stiffness
  • WOMAC score of ≤ 75 in the target knee
  • Brandt Radiographic Grading Scale of Osteoarthritis grade 1 and 2

排除标准

  • evidence of secondary knee osteoarthritis
  • severe osteoarthritis (Joint space width - JSW < 2 mm)
  • prior intra articular injections within the previous one year prior to inclusion
  • patients with clinically significant systemic disease

结局指标

主要结局

WOMAC (Western Ontario and McMaster Universities Arthritis Index)

时间窗: 1 year

次要结局

  • Six minute walk distance(1 year)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验